Renaissance Capital logo

PTC Therapeutics Priced, Nasdaq: PTCT

Biotech targeting rare forms of muscular dystrophy and cystic fibrosis.

Industry: Health Care

First Day Return: +9.9%

Biotech targeting rare forms of muscular dystrophy and cystic fibrosis.
IPO Data
IPO Date 06/19/2013
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $126
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters South Plainfield, NJ, United States
Founded 1998
Employees at IPO 127
Website www.ptcbio.com

PTC Therapeutics (PTCT) Performance

Created with Highcharts 10.3.2Chart context menuPTCT vs. IPO Index (IPOUSA)2014201520162017201820192020202120222023202420250%+ 200%+ 400%-200%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index